Oriental Aromatics Ltd
Oriental Aromatics Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #57 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
The company targets a sales growth trajectory of 10% to 15% in the next one year. The company is targeting a 10%-15% growth in sales in the next one year, indicating healthy near-term revenue growth.
From Oriental Aromatics Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- The company targets a sales growth trajectory of 10% to 15% in the next one year.
- Volume growth is emphasized, with a focus on sustained demand across key product categories.
- Operational momentum and a healthy pipeline of customers provide a foundation for growth in Q2 and Q3.
- The Mahad plant's capacity utilization is expected to improve from the current 50%-60%, supporting incremental sales.
- Continued focus on expanding customer relationships and converting development projects into commercial businesses.
- The company aims to sustain volume growth while improving margins through better product mix, process optimization, and cost management.
2 more points from Oriental Aromatics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Oriental Aromatics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The Mahad facility is a long-term strategic investment with current Phase-1 completed; designed for a large number of products and future expansions.
- Mahad is currently operating at 50%-60% utilization with plans to increase to 75%-80%, aiming to become EBITDA positive and contribute meaningfully to profitability.
- The company is focused on maximizing utilization and improving profitability from existing assets before undertaking major expansionary investments.
2 more points from Oriental Aromatics Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Oriental Aromatics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The management highlighted a healthy pipeline and a strong increase in physical volumes, indicating active order inflow.
- Fragrance division’s brief pipeline remains healthy with a focus on expanding customer relationships and converting development projects into commercial business.
- The Specialty Aroma Ingredients business delivered healthy year-on-year growth amid strong global competition.
- For Mahad plant, the company is actively working on accelerating customer approvals and commercial allocations.
2 more points from Oriental Aromatics Ltd's call on order book
Create a free account to keep reading this call
Oriental Aromatics Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹282 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Oriental Aromat.'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Oriental Aromatics Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Oriental Aromatics Ltd Q1 FY27 results?
The company targets a sales growth trajectory of 10% to 15% in the next one year. The company is targeting a 10%-15% growth in sales in the next one year, indicating healthy near-term revenue growth.
What is Oriental Aromatics Ltd share price analysis?
Oriental Aromatics Ltd currently shows a below-average growth signal. The stock trades at a P/E of 220.2 with a market cap of ₹1,171 Cr. Investors should review the full earnings analysis for detailed insights.
Is Oriental Aromatics Ltd planning capital expenditure?
The Mahad facility is a long-term strategic investment with current Phase-1 completed; designed for a large number of products and future expansions.
Keep Oriental Aromatics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.